Cary Street Partners Investment Advisory’s Keurig Dr Pepper KDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
9,937
-243
-2% -$7.08K 0.07% 284
2026
Q1
$268K Buy
10,180
+1,183
+13% +$33.2K 0.07% 289
2025
Q4
$252K Buy
8,997
+1,485
+20% +$40.8K 0.07% 283
2025
Q3
$192K Buy
7,512
+133
+2% +$4.17K 0.08% 278
2025
Q2
$244K Buy
7,379
+122
+2% +$4.13K 0.12% 193
2025
Q1
$248K Buy
7,257
+1,817
+33% +$59K 0.14% 177
2024
Q4
$175K Sell
5,440
-1,893
-26% -$64K 0.11% 196
2024
Q3
$275K Sell
7,333
-1,283
-15% -$45.1K 0.01% 644
2024
Q2
$288K Buy
+8,616
New +$286K 0.01% 609
2023
Q4
Sell
-3,312
Closed -$105K 1265
2023
Q3
$105K Buy
3,312
+2,572
+348% +$84.9K 0.01% 695
2023
Q2
$23.1K Buy
740
+49
+7% +$1.61K ﹤0.01% 1008
2023
Q1
$24.4K Buy
691
+63
+10% +$2.21K ﹤0.01% 920
2022
Q4
$22.4K Buy
+628
New +$23.5K ﹤0.01% 946
2020
Q4
Sell
-248
Closed -$7K 635
2020
Q3
$7K Buy
+248
New +$7.27K ﹤0.01% 808

Other funds holding KDP

Cary Street Partners Investment Advisory's KDP Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Keurig Dr Pepper (KDP) stake by 2.4% in Q2 2026, selling an estimated $7.08K and leaving 9,937 shares worth $325K. The position accounts for 0.07% of the portfolio, ranked #284.

Cary Street Partners Investment Advisory first reported a position in KDP in Q3 2020 and has held it in 14 quarters since. 557 funds tracked by Wall St. Rank hold KDP as of Q2 2026.

  • Cary Street Partners Investment Advisory held 9,937 shares of Keurig Dr Pepper worth $325K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 243 Keurig Dr Pepper shares in Q2 2026, an estimated $7.08K.
  • Keurig Dr Pepper made up 0.07% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #284 holding.
  • Cary Street Partners Investment Advisory first reported a position in Keurig Dr Pepper in Q3 2020 and has held it in 14 quarters since.
  • 557 funds tracked by Wall St. Rank held Keurig Dr Pepper as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.